ATE314460T1 - Antigenpräsentierende zellen, ein verfahren zur deren herstellung und deren verwendung als zelluläre impfstoffen - Google Patents

Antigenpräsentierende zellen, ein verfahren zur deren herstellung und deren verwendung als zelluläre impfstoffen

Info

Publication number
ATE314460T1
ATE314460T1 AT97924012T AT97924012T ATE314460T1 AT E314460 T1 ATE314460 T1 AT E314460T1 AT 97924012 T AT97924012 T AT 97924012T AT 97924012 T AT97924012 T AT 97924012T AT E314460 T1 ATE314460 T1 AT E314460T1
Authority
AT
Austria
Prior art keywords
macrophages
antigen
allogenic
determined
yeast
Prior art date
Application number
AT97924012T
Other languages
English (en)
Inventor
Mohamed Chokri
Jacques Bartholeyns
Jean-Loup Romet-Lemonne
Original Assignee
Idm Immuno Designed Molecules
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idm Immuno Designed Molecules filed Critical Idm Immuno Designed Molecules
Application granted granted Critical
Publication of ATE314460T1 publication Critical patent/ATE314460T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/17—Monocytes; Macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4202—Receptors, cell surface antigens or cell surface determinants
    • A61K40/4224—Molecules with a "CD" designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/80—Neurotransmitters; Neurohormones
    • C12N2501/82—Histamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97924012T 1996-05-21 1997-05-15 Antigenpräsentierende zellen, ein verfahren zur deren herstellung und deren verwendung als zelluläre impfstoffen ATE314460T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96401099A EP0808897A1 (de) 1996-05-21 1996-05-21 Antigenpräsentierende Zellen, ein Verfahren zur deren Herstellung und deren Verwendung als zelluläre Impfstoffen
PCT/EP1997/002703 WO1997044441A1 (en) 1996-05-21 1997-05-15 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines

Publications (1)

Publication Number Publication Date
ATE314460T1 true ATE314460T1 (de) 2006-01-15

Family

ID=8225258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97924012T ATE314460T1 (de) 1996-05-21 1997-05-15 Antigenpräsentierende zellen, ein verfahren zur deren herstellung und deren verwendung als zelluläre impfstoffen

Country Status (9)

Country Link
US (3) US20020182725A1 (de)
EP (2) EP0808897A1 (de)
JP (1) JP3428025B2 (de)
AT (1) ATE314460T1 (de)
AU (1) AU732536C (de)
DE (1) DE69734989T2 (de)
DK (1) DK0925356T3 (de)
ES (1) ES2256886T3 (de)
WO (1) WO1997044441A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU773561B2 (en) 1998-03-30 2004-05-27 I.D.M. Immuno-Designed Molecules Stimulated monocyte derived cells, their preparation and uses
WO1999053027A1 (en) * 1998-04-09 1999-10-21 I.D.M. Immuno-Designed Molecules Use of monocytes derived cells and antibodies in a synergic way for optimal induction of immunotherapeutic efficiency
US20020168347A1 (en) * 1998-04-09 2002-11-14 Jacques Bartholeyns Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
EP1078043A1 (de) * 1998-05-11 2001-02-28 I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale Neue apoptotische körper, diese enthaltente zellen aus monocyten, verfahren zür deren herstellung und deren verwendung als impstoffen
DE19950262C2 (de) * 1999-10-18 2001-09-13 Martin Foermer Verfahren zur Durchführung eines durchflusszytometrischen Phagozytosetests
CA2394831A1 (en) * 2000-01-11 2001-07-19 Maxygen, Inc. Monocyte-derived dendritic cell subsets
US20020094323A1 (en) 2000-10-12 2002-07-18 Kristoffer Hellstrand Methods and compositions for promoting the maturation of monocytes
WO2002046376A1 (en) * 2000-12-07 2002-06-13 I.D.M. Immuno-Designed Molecules Dehydrated antigen presenting cells usable for vaccination
FR2819263B1 (fr) * 2001-01-10 2003-04-11 Lco Sante Procede de maturation des cellules dendritiques et d'activation des macrophages avec le ru 41740
DE10135615A1 (de) * 2001-07-21 2003-02-06 Genethor Gmbh Ex vivo Selektion von T-Zellen
EP1409648A1 (de) * 2001-07-25 2004-04-21 I.D.M. Immuno-Designed Molecules Neue isolierte dendritische zellen, ein prozess umdiese herzustellen, und deren verwendung in pharmazeutischen zusammensetzungen
US7695725B2 (en) * 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
KR101173871B1 (ko) * 2003-02-06 2012-08-16 앤저 테라퓨틱스 인코퍼레이티드 변형된 독립생존 미생물, 백신 조성물 및 그것의 사용방법
KR101192652B1 (ko) * 2003-02-06 2012-10-19 앤저 테라퓨틱스 인코퍼레이티드 비포식 세포로의 침투가 약화된 리스테리아, 리스테리아를 포함하는 백신, 및 그것의 사용방법
DE10339905B4 (de) 2003-08-29 2009-04-23 Kist-Europe Forschungsgesellschaft Mbh Implantierbarer Mikrozellprozessor zur Krankheitsbehandlung
US7842289B2 (en) * 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
JPWO2019244973A1 (ja) * 2018-06-20 2021-07-08 中外製薬株式会社 標的細胞に対する免疫反応を活性化する方法およびその組成物
WO2021011907A1 (en) * 2019-07-18 2021-01-21 Gpb Scientific, Inc. Ordered processing of blood products to produce therapeutically active cells
CN113244383B (zh) * 2021-06-11 2021-09-10 诺赛联合(北京)生物医学科技有限公司 一种dc瘤苗制备方法及其在肿瘤治疗中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0553244T4 (da) * 1990-10-05 2005-08-01 Celldex Therapeutics Inc Målrettet immunostimulering med bispecifikke reagenser
DE69333433T2 (de) * 1992-04-01 2004-12-02 The Rockefeller University Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung
US6001351A (en) * 1993-05-18 1999-12-14 I.D.M. Immuno-Designed Molecules Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
US5662899A (en) * 1993-05-18 1997-09-02 I.D.M. Immuno-Designed Molecules Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
US6540994B1 (en) * 1997-07-18 2003-04-01 I.D.M. Immuno-Designed Molecules Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
FR2729570A1 (fr) * 1995-01-24 1996-07-26 Idm Immuno Designed Molecules Procede de preparation de macrophages actives, trousses et compositions pour la mise en oeuvre de ce procede

Also Published As

Publication number Publication date
AU732536C (en) 2002-03-21
EP0808897A1 (de) 1997-11-26
ES2256886T3 (es) 2006-07-16
DK0925356T3 (da) 2006-02-13
EP0925356B1 (de) 2005-12-28
AU2961597A (en) 1997-12-09
US20020192192A1 (en) 2002-12-19
AU732536B2 (en) 2001-04-26
JP3428025B2 (ja) 2003-07-22
DE69734989D1 (de) 2006-02-02
US20020182725A1 (en) 2002-12-05
EP0925356A1 (de) 1999-06-30
WO1997044441A1 (en) 1997-11-27
US20020192193A1 (en) 2002-12-19
DE69734989T2 (de) 2006-06-22
JP2000503545A (ja) 2000-03-28

Similar Documents

Publication Publication Date Title
ATE314460T1 (de) Antigenpräsentierende zellen, ein verfahren zur deren herstellung und deren verwendung als zelluläre impfstoffen
Simon Measurement of the cyanophycin granule polypeptide contained in the blue-green alga Anabaena cylindrica
JP4091052B2 (ja) 遠心発酵プロセス
Hoppe Microbial extracellular enzyme activity: a new key parameter in aquatic ecology
US9556413B2 (en) System and methods for anaerobic environmental microbial compartmentalized cultivation
Bruley-Rosset et al. Interleukin-1 synthesis and activity in aged mice
US6387651B1 (en) Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a microwell device
Langer Biosynthesis of glycosaminoglycans in foraminifera: A review
Imhoff Rhodopseudomonas marina sp. nov., a new marine phototrophic purple bacterium
US4745064A (en) Process for the degradation of s-triazine derivatives in aqueous solutions
GR3016991T3 (en) Culture and detection method for sterile-filterable autonomously replicating biological particles.
Leinfelder et al. A highly sensitive cell assay for validation of purification regimes of alginates
Keith et al. Isolation of new types of sulphate‐reducing bacteria from estuarine and marine sediments using chemostat enrichments
Kaznowski Identification of Aeromonas strains of different origin to the genomic species level
Nishioka et al. Analysis of photoenzymatic repair of UV lesions in DNA by single light flashes IX. Excess production of photoreactivating enzyme inE. Coli Bs-1-160 under different growth conditions, and its suppression by adenine
Guerra et al. Biochemical and microbiological tools for the evaluation of environmental quality of a coastal lagoon system in Southern Brazil
EP4299712A1 (de) Zellverarbeitungssystem, zellverarbeitungsverfahren und lerndatenerzeugungsverfahren
Ebing et al. Ecochemical assessment of environmental chemicals: Draft guideline of the test procedure to evaluate metabolism and degradationof chemicals by plant cell cultures
Babu et al. Intensity heteromorphisms of human chromosome 15p by DA/DAPI technique
JP2002515239A (ja) 改善および発酵のための方法および装置
JP4217046B2 (ja) 疎水性担体への菌体の固定化
CN112689669B (zh) 用于培养目的微生物的方法及相关设备
Helisch et al. Preparatory ground-based experiments on cultivation of Chlorella vulgaris for the ISS experiment PBR@ LSR
O'Brien et al. Induction of mutations in TK6 human lymphoblastoid cells by ethyl methanesulphonate, benzo [a] pyrene and benzidine
CN116731327B (zh) 一种温敏性细胞微载体及其制备方法，以及培养细胞的方法

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties